Mirador Capital Partners’s Pfizer PFE Stock Holding History

Mirador Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Sell	45,835 -575	-1%	-$15K	0.14%	100
2026 Q1	$1.3M	Buy	46,410 +614	+1%	+$16.3K	0.18%	75
2025 Q4	$1.14M	Sell	45,796 -2,664	-5%	-$67.2K	0.16%	94
2025 Q3	$1.23M	Sell	48,460 -115	-0.2%	-$2.84K	0.18%	88
2025 Q2	$1.18M	Buy	48,575 +11,662	+32%	+$272K	0.19%	83
2025 Q1	$935K	Buy	36,913 +945	+3%	+$24.7K	0.16%	95
2024 Q4	$954K	Buy	35,968 +1,552	+5%	+$42.1K	0.17%	89
2024 Q3	$996K	Buy	34,416 +24,674	+253%	+$720K	0.18%	82
2024 Q2	$273K	Buy	9,742 +691	+8%	+$19K	0.05%	161
2024 Q1	$251K	Sell	9,051 -72,596	-89%	-$2.01M	0.05%	176
2023 Q4	$2.35M	Buy	81,647 +5,084	+7%	+$154K	0.5%	49
2023 Q3	$2.54M	Buy	76,563 +493	+0.6%	+$17.4K	0.58%	44
2023 Q2	$2.79M	Buy	76,070 +67,017	+740%	+$2.61M	0.66%	44
2023 Q1	$369K	Sell	9,053 -6,462	-42%	-$279K	0.09%	137
2022 Q4	$795K	Buy	15,515 +27	+0.2%	+$1.29K	0.19%	83
2022 Q3	$678K	Sell	15,488 -1,021	-6%	-$49.6K	0.16%	87
2022 Q2	$866K	Sell	16,509 -68	-0.4%	-$3.46K	0.2%	82
2022 Q1	$858K	Sell	16,577 -420	-2%	-$21.8K	0.17%	93
2021 Q4	$1M	Sell	16,997 -5,083	-23%	-$252K	0.21%	91
2021 Q3	$950K	Sell	22,080 -12	-0.1%	-$532	0.22%	100
2021 Q2	$865K	Buy	22,092 +247	+1%	+$9.61K	0.2%	101
2021 Q1	$791K	Sell	21,845 -31,884	-59%	-$1.13M	0.2%	102
2020 Q4	$1.98M	Buy	53,729 +1,417	+3%	+$52K	0.54%	62
2020 Q3	$1.82M	Sell	52,312 -11,084	-17%	-$389K	0.57%	53
2020 Q2	$1.97M	Buy	63,396 +8,094	+15%	+$275K	0.74%	46
2020 Q1	$2.02M	Buy	55,302 +7,899	+17%	+$269K	0.84%	39
2019 Q4	$1.76M	Buy	47,403 +548	+1%	+$19.5K	0.71%	49
2019 Q3	$1.6M	Buy	46,855 +571	+1%	+$20.8K	0.71%	46
2019 Q2	$1.9M	Buy	46,284 +198	+0.4%	+$7.86K	0.94%	37
2019 Q1	$1.86M	Sell	46,086 -2,320	-5%	-$92.9K	1.01%	35
2018 Q4	$2M	Sell	48,406 -3,798	-7%	-$158K	1.24%	28
2018 Q3	$2.18M	Buy	52,204 +745	+1%	+$28.7K	1.07%	30
2018 Q2	$1.77M	Sell	51,459 -137	-0.3%	-$4.68K	0.96%	37
2018 Q1	$1.79M	Buy	51,596 +1,798	+4%	+$61.8K	1.25%	30
2017 Q4	$1.71M	Buy	49,798 +1,322	+3%	+$45.1K	0.94%	41
2017 Q3	$1.66M	Buy	48,476 +598	+1%	+$19.2K	0.97%	42
2017 Q2	$1.53M	Buy	47,878 +2,866	+6%	+$90.4K	0.94%	33
2017 Q1	$1.46M	Buy	45,012 +6,809	+18%	+$215K	1.06%	30
2016 Q4	$1.18M	Sell	38,203 -420	-1%	-$12.8K	0.94%	35
2016 Q3	$1.24M	Sell	38,623 -908	-2%	-$30.4K	1.09%	31
2016 Q2	$1.32M	Sell	39,531 -1,088	-3%	-$34.7K	1.33%	28
2016 Q1	$1.14M	Buy	+40,619	New	+$1.16M	1.27%	36

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Mirador Capital Partners's PFE Position: Q2 2026 in Review

Mirador Capital Partners reduced its Pfizer (PFE) stake by 1.2% in Q2 2026, selling an estimated $15K and leaving 45,835 shares worth $1.1M. The position accounts for 0.14% of the portfolio, ranked #100.

Mirador Capital Partners first reported a position in PFE in Q1 2016 and has held it in 42 quarters since. The position peaked at $2.79M in Q2 2023. 799 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Mirador Capital Partners held 45,835 shares of Pfizer worth $1.1M as of Q2 2026.
Mirador Capital Partners sold 575 Pfizer shares in Q2 2026, an estimated $15K.
Pfizer made up 0.14% of Mirador Capital Partners's portfolio in Q2 2026, its #100 holding.
Mirador Capital Partners first reported a position in Pfizer in Q1 2016 and has held it in 42 quarters since.
Mirador Capital Partners's Pfizer position peaked at $2.79M in Q2 2023.
799 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mirador Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.